gyki 52466 has been researched along with Anoxia, Brain in 5 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schurr, A | 1 |
| Payne, RS | 1 |
| Rigor, BM | 1 |
| Jaw, SP | 1 |
| Vuong, QT | 1 |
| Nguyen, M | 1 |
| Chi, OZ | 1 |
| Chang, Q | 1 |
| Wang, G | 1 |
| Liu, X | 1 |
| Weiss, HR | 2 |
| Williams, JA | 1 |
| Tekkök, SB | 1 |
| Goldberg, MP | 1 |
5 other studies available for gyki 52466 and Anoxia, Brain
| Article | Year |
|---|---|
Protection by MK-801 against hypoxia-, excitotoxin-, and depolarization-induced neuronal damage in vitro.
Topics: 2-Amino-5-phosphonovalerate; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anti-Anxiety | 1995 |
Effects of glutamate receptor antagonists on posthypoxic myoclonus in rats.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anti-Anxiety Agents; Benzodiazepines; Binding, Competitive; Di | 1996 |
A nonNMDA antagonist, GYKI 52466 improves microscopic O2 balance in the cortex during focal cerebral ischemia.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Blood Pressure; Brain Ischemia; Cerebral Cortex; Cere | 1999 |
Effect of AMPA receptor blockade on the control of cerebral O2 supply/consumption balance in newborn pigs.
Topics: Animals; Animals, Newborn; Benzodiazepines; Brain; Cerebral Cortex; Cerebrovascular Circulation; Fem | 1999 |
Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter.
Topics: Action Potentials; Animals; Anti-Anxiety Agents; Axons; Benzodiazepines; Calcium; Cell Death; Cell H | 2001 |